126 related articles for article (PubMed ID: 37926942)
1. Association Between Use of Fluoroquinolones and Risk of Mitral or Aortic Valve Regurgitation: A Nationwide Cohort Study.
Dong YH; Wang JL; Chang CH; Lin JW; Chen YA; Chen CY; Toh S
Clin Pharmacol Ther; 2024 Jan; 115(1):147-157. PubMed ID: 37926942
[TBL] [Abstract][Full Text] [Related]
2. Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.
Dong YH; Chang CH; Wang JL; Wu LC; Lin JW; Toh S
JAMA Intern Med; 2020 Dec; 180(12):1587-1595. PubMed ID: 32897358
[TBL] [Abstract][Full Text] [Related]
3. Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.
Gopalakrishnan C; Bykov K; Fischer MA; Connolly JG; Gagne JJ; Fralick M
JAMA Intern Med; 2020 Dec; 180(12):1596-1605. PubMed ID: 32897307
[TBL] [Abstract][Full Text] [Related]
4. Association of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm.
Newton ER; Akerman AW; Strassle PD; Kibbe MR
JAMA Surg; 2021 Mar; 156(3):264-272. PubMed ID: 33404647
[TBL] [Abstract][Full Text] [Related]
5. Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population-based propensity score-matched cohort study.
Garg M; Venugopalan V; Vouri SM; Diaby V; Iovine NM; Park H
Pharmacotherapy; 2023 Sep; 43(9):883-893. PubMed ID: 37381584
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis.
Assimon MM; Pun PH; Wang LC; Al-Khatib SM; Brookhart MA; Weber DJ; Winkelmayer WC; Flythe JE
JAMA Cardiol; 2022 Jan; 7(1):75-83. PubMed ID: 34668928
[TBL] [Abstract][Full Text] [Related]
7. Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection.
Brown JP; Wing K; Leyrat C; Evans SJ; Mansfield KE; Wong AYS; Smeeth L; Galwey NW; Douglas IJ
JAMA Cardiol; 2023 Sep; 8(9):865-870. PubMed ID: 37585175
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness and Harms of Antibiotics for Outpatient Diverticulitis : Two Nationwide Cohort Studies.
Gaber CE; Kinlaw AC; Edwards JK; Lund JL; Stürmer T; Peacock Hinton S; Pate V; Bartelt LA; Sandler RS; Peery AF
Ann Intern Med; 2021 Jun; 174(6):737-746. PubMed ID: 33617725
[TBL] [Abstract][Full Text] [Related]
9. Oral fluoroquinolones and risk of aortic or mitral regurgitation: a nationwide nested case-control study.
Strange JE; Holt A; Blanche P; Gislason G; Torp-Pedersen C; Christensen DM; Hansen ML; Lamberts M; Schou M; Olesen JB; Fosbøl EL; Køber L; Rasmussen PV
Eur Heart J; 2021 Aug; 42(30):2899-2908. PubMed ID: 34245252
[TBL] [Abstract][Full Text] [Related]
10. Association Between Aortic Aneurysm and Aortic Dissection With Fluoroquinolones Use in Patients With Urinary Tract Infections: A Population-Based Cohort Study.
Chen YY; Yang SF; Yeh HW; Yeh YT; Huang JY; Tsao SL; Yeh CB
J Am Heart Assoc; 2022 Mar; 11(6):e023267. PubMed ID: 35229623
[TBL] [Abstract][Full Text] [Related]
11. Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy.
Morales D; Pacurariu A; Slattery J; Pinheiro L; McGettigan P; Kurz X
JAMA Neurol; 2019 Jul; 76(7):827-833. PubMed ID: 31034074
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolones vs. amoxicillin-clavulanate or ampicillin-sulbactam were not linked to aortic aneurysm or dissection.
Fekete T
Ann Intern Med; 2021 Feb; 174(2):JC22. PubMed ID: 33524287
[TBL] [Abstract][Full Text] [Related]
13. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study.
Daneman N; Lu H; Redelmeier DA
BMJ Open; 2015 Nov; 5(11):e010077. PubMed ID: 26582407
[TBL] [Abstract][Full Text] [Related]
15. Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation.
Etminan M; Sodhi M; Ganjizadeh-Zavareh S; Carleton B; Kezouh A; Brophy JM
J Am Coll Cardiol; 2019 Sep; 74(11):1444-1450. PubMed ID: 31514945
[TBL] [Abstract][Full Text] [Related]
16. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
Harbarth S; Harris AD; Carmeli Y; Samore MH
Clin Infect Dis; 2001 Nov; 33(9):1462-8. PubMed ID: 11588690
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).
Effa EE; Lassi ZS; Critchley JA; Garner P; Sinclair D; Olliaro PL; Bhutta ZA
Cochrane Database Syst Rev; 2011 Oct; 2011(10):CD004530. PubMed ID: 21975746
[TBL] [Abstract][Full Text] [Related]
18. Varicose veins are associated with an increased risk of mitral valve regurgitation: a nationwide population-based cohort study.
Lee ML; Chou WY; Kao YW; Chen MC; Shia BC; Lee PS; Chen TH; Lin TY; Huang SY; Su YB; Chiu WC
Int Angiol; 2023 Aug; 42(4):352-361. PubMed ID: 37347156
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: an updated systematic review and meta-analysis including 53,651,283 patients.
Fatima K; Uzair SU; Salman A; Jawed A; Husain MA; Shah MG; Hasnain MA; Jawed A; Vohra LI; Lal PM
Minerva Cardiol Angiol; 2023 Oct; 71(5):485-493. PubMed ID: 36468763
[TBL] [Abstract][Full Text] [Related]
20. Systemic antibiotics for treating diabetic foot infections.
Selva Olid A; Solà I; Barajas-Nava LA; Gianneo OD; Bonfill Cosp X; Lipsky BA
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009061. PubMed ID: 26337865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
